GSS Genetic Signatures Ltd
- 0.720
- +0.030+4.35%
Genetic Signatures Ltd News
Why Genetic Signatures, Retail Food Group, Smartpay, and St Barbara Shares Are Tumbling Today
In afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is on course to record a decent gain. At the time of writing, the benchmark index is up 0.75% to 7,784.4 points.
Genetic Signatures Ceases Development of EasyScreen Essentials Respiratory Product for US Market; Shares Down 11%
Genetic Signatures (ASX:GSS) has decided to cease the development of the EasyScreen Essentials Respiratory Detection Kit for the US market amid "increased competition" and "changing market dynamics,"
Genetic Signatures' Sales Drop in Fiscal Q3
Genetic Signatures (ASX:GSS) logged sales of AU$1.7 million for the third quarter of fiscal 2024, down from AU$2 million in the year-ago period, according to an April 26 filing with the Australian bou
Shareholders in Genetic Signatures (ASX:GSS) Are in the Red If They Invested Three Years Ago
Genetic Signatures Price Target Cut 6.3% to A$0.75/Share by Bell Potter
Genetic Signatures Price Target Cut 6.3% to A$0.75/Share by Bell Potter
Genetic Signatures Completes Rights Issue
Genetic Signatures (ASX:GSS) completed an underwritten rights issue on Jan. 18, the molecular diagnostics company said Wednesday. The rights issue closed with valid applications for entitlements of AU
Genetic Signatures Target Price Cut 3.6% to A$0.80/Share by Bell Potter>GSS.AU
Genetic Signatures Target Price Cut 3.6% to A$0.80/Share by Bell Potter>GSS.AU
These Small Cap ASX Shares Can Rise 30% to 80%: Bell Potter
There could be some very big returns on offer at the small side of the market according to analysts at Bell Potter.
Genetic Signatures Closes AU$8 Million Placement
Genetic Signatures (ASX:GSS) completed a placement, raising proceeds of AU$8 million, the molecular diagnostics firm said Friday. Under the placement, the company offered 21.5 million new fully paid o
Genetic Signatures to Raise AU$15.9 Million via Placement
Molecular diagnostics firm Genetic Signatures (ASX:GSS) plans to raise a total of AU$15.9 million via a placement of 43.1 million new fully paid ordinary shares to its new and existing, sophisticated
Genetic Signatures Raises AU$16 Million From Share Sale
Genetic Signatures (ASX:GSS) has raised AU$15.9 million from a sale of 43.1 million new shares to existing stockholders, institutional investors and some company directors at AU$0.37 apiece. Proceeds
Genetic Signatures Secures AU$7 Million R&D Tax Incentive Rebate for Fiscal Year 2023
Genetic Signatures (ASX:GSS) secured a AU$6.9 million rebate from the Australian government's research and development tax incentive scheme for the fiscal year ended June 30, 2023, the molecular diagn
Genetic Signatures Fiscal Q1 Sales Fall 64% Due to Performance Issue
Genetic Signatures (ASX:GSS) reported a 64% decline in sales to AU$1.6 million for the first quarter ended September. The quarter-over-quarter decline was due to a performance issue that temporarily i
Genetic Signatures Shows Value After Shares Tumble -- Market Talk
0104 GMT - Disease-detection developer Genetic Signatures gets upgraded to buy from hold by Bell Potter analyst Anubhav Saxena following a 40% decline in its share price over the past seven months. Sa
Genetic Signatures Upgraded to Buy From Hold by Bell Potter
Genetic Signatures Upgraded to Buy From Hold by Bell Potter
Genetic Signatures Submits 510(k) Application to the US FDA to Market Parasite Detection Kit in the US; Shares Jump 17%
Genetic Signatures (ASX:GSS) submitted a 510(k) application to the US FDA to secure a regulatory clearance to market its EasyScreen gastrointestinal parasite detection kit in the US, the molecular dia
Analysts Are Bullish on Top Healthcare Stocks: Monash IVF Group Ltd (AU:MVF), Genetic Signatures Ltd. (AU:GSS)
Caroline Waldron Buys 16,700 Shares of Genetic Signatures Limited (ASX:GSS) Stock
Genetic Signatures Limited (ASX:GSS – Get Rating) insider Caroline Waldron acquired 16,700 shares of the firm's stock in a transaction on Tuesday, February 28th. The shares were bought at an average c
Genetic Signatures Target Price Cut 2.2% to A$0.88/Share by Bell Potter>GSS.AU
Genetic Signatures Target Price Cut 2.2% to A$0.88/Share by Bell Potter>GSS.AU
Analysis
Price Target
No Data
